Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults

NCT04494373 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Bone Metastasis From Solid Tumors

Interventions

DRUG: HS-20090
DRUG: Xgeva®

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.